IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
